InvestorsHub Logo
Followers 19
Posts 3200
Boards Moderated 2
Alias Born 06/05/2020

Re: Sukyamadda post# 17472

Thursday, 05/25/2023 8:06:05 PM

Thursday, May 25, 2023 8:06:05 PM

Post# of 20325
There is certainly other "potential" competition

If you read the links there have been >1 about Shionogi and their 3CL Protease Inhibitor. It is just starting PH III RCT.
There are 1-2 others but none FDA approved xcept Pax.
Molnupiravir had EUA but not sure current--it does not work very well at keeping people out of hospital IIRC

But no other OTC 3CL PI

Sad there is no $$ for TolloVIR trial--guess can dilute more LOL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News